-
BME 695L Lecture 15: GMP and Issues of Quality Control Manufacture of Nanodelivery Systems
02 Dec 2011 | Online Presentations | Contributor(s): James Leary
See references below for related reading.
15.1 Overview
15.1.1 What does cGMP mean?
15.1.2 Why GMP? Controlling processes means more predictable …
-
BME 695L Lecture 16: FDA and EPA Regulatory Issues
02 Dec 2011 | Online Presentations | Contributor(s): James Leary
See references below for related reading.
16.1 Introduction and overview
16.1.1 How does the FDA think about nanomedical systems?
16.1.2 The 2006 Nanotechnology Task …
-
BME 695L Lecture 12: Assessing Drug Efficacy and Nanotoxicity at the Single Cell Level
22 Nov 2011 | Online Presentations | Contributor(s): James Leary
See references below for related reading.
12.1 Introduction to measures of efficacy for nanomedicine
12.1.1 for evaluation purposes, does structure/size reveal function?
12.1.2 nanomedical treatment at the …
-
BME 695L Lecture 13: Designing Nanomedical Systems (NMS) for In-vivo Use
22 Nov 2011 | Online Presentations | Contributor(s): James Leary
See references below for related reading.
13.1 Bringing in-vivo considerations into NMS design
13.1.1 the in-vitro to ex-vivo to in-vivo paradigm
13.1.1.1 In-vitro - importance of …
-
BME 695L Lecture 14: Designing and Testing Integrated Nanomedical Systems
22 Nov 2011 | Online Presentations | Contributor(s): James Leary
See references below for related reading.
14.1 Introduction to integrated designs
14.1.1 “Total design” but there is some order in the design process
14.1.2 A brief outline of the total design …